| Organism |
Size (Mb) |
G+C |
Status |
Funding |
 |
 |
 |
 |
 |
| Alivibrio salmonicida |
3.33 + 1.21 |
39.0% |
Hjerde et al., BMC Genomics 9, 616 (2008) |
Wellcome Trust |
| Bacteriovorax marinus |
3.44 |
36.7% |
Finished |
Wellcome Trust |
| Bacteroides fragilis NCTC9343 |
5.20 |
43.1% |
Cerdeño-Tárraga et al., Science 307, 1463-1465 (2005) |
Beowulf Genomics |
| Bacteroides fragilis 638R |
5.373 |
43.4% |
Finished |
Beowulf Genomics |
| Bordetella avium |
3.73 |
61.6% |
Sebaihia et al., J. Bacteriol. 188, 6002-6005 (2006) |
USDA |
| Bordetella bronchiseptica RB50 |
5.34 |
68.1% |
Parkhill et al. Nature Genetics 35 32-40 (2003) |
Beowulf Genomics |
| Bordetella bronchiseptica strain 253 |
~5 |
~68% |
Shotgun in progress |
Wellcome Trust |
| Bordetella bronchiseptica MO149 |
~5 |
~68% |
Shotgun in progress |
Wellcome Trust |
| Bordetella parapertussis 12822 |
4.77 |
68.1% |
Parkhill et al. Nature Genetics 35 32-40 (2003) |
Beowulf Genomics |
| Bordetella parapertussis Bpp5 |
~5 |
~68% |
Shotgun in progress |
Wellcome Trust |
| Bordetella pertussis Tohama I |
4.09 |
67.7% |
Parkhill et al. Nature Genetics 35 32-40 (2003) |
Beowulf Genomics |
| Bordetella pertussis strain 18323 |
~5 |
~68% |
shotgun in progress |
Wellcome Trust |
Burkholderia cenocepacia
(formerly Burkholderia cepacia genomovar III) |
3.87 + 3.22 + 0.88 |
66.9% |
Holden et al., J. Bacteriol. 191, 261-277 (2009) |
Beowulf Genomics |
| Burkholderia pseudomallei |
4.07 + 3.17 |
68% |
Holden et al., Proc. Natl. Acad. Sci. USA 101, 14240-14245 (2004) |
Beowulf Genomics |
| Campylobacter jejuni |
1.64 |
30.6% |
Parkhill et al., Nature 403, 665-668 (2000) |
Beowulf Genomics |
| Chlamydia trachomatis serovar A |
1.052 |
41.3% |
Finished |
Wellcome Trust |
| Chlamydia trachomatis serovar B |
1.052 |
41.3% |
Seth-Smith et al., BMC Genomics 10, 239 (2009) |
Wellcome Trust |
| Chlamydia trachomatis Jali |
1.051 |
41.3% |
Seth-Smith et al., BMC Genomics 10, 239 (2009) |
Wellcome Trust |
| Chlamydia trachomatis L2 |
1.039 |
41.3 % |
Thomson et al., Genome Research 18, 161-171 |
Wellcome Trust |
| Chlamydophila abortus |
1.14 |
39.9% |
Thomson et al., Genome Research 15, 629-640 |
The Scottish Office |
| Citrobacter freundii ballerup 7851 |
4.905 |
52% |
357 contigs; Petty et al., J. Bacteriol., 192, 525-538 (2010) |
Wellcome Trust |
| Citrobacter rodentium |
5.347 |
54.7% |
Petty et al., J. Bacteriol. 192, 525-538 (2010) |
Wellcome Trust |
| Clavibacter michiganensis |
3.404 |
72.38% |
Bentley et al., J. Bacteriol. epublication (2008) |
USDA |
| Clostridium botulinum Hall strain A |
3.89 |
28.2% |
Sebaihia et al., Genome Research epublication (2007) |
Beowulf Genomics |
| Clostridium botulinum 17B |
~3.9 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile 630 |
4.29 |
29.06% |
Sebaihia et al., Nature Genetics 38, 779-786 (2006) |
Beowulf Genomics |
| Clostridium difficile 196 |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile BI1 |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile M120 |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile M68 |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile SM |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile CF5 |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Clostridium difficile 855 |
~4.3 |
~30% |
Finishing/gap closure |
Wellcome Trust |
| Corynebacterium diphtheriae |
2.49 |
52% |
Cerdeño-Tárraga et al., Nucleic Acids Research 31(22), 6516-6523 (2003) |
Beowulf Genomics |
| Ehrlichia (Cowdria) ruminantium |
1.516 |
27.5% |
Collins et al., Proc. Natl. Acad. Sci. USA 102, 838-843 (2005) |
NWO |
| Erwinia amylovora |
3.81 |
53.5% |
Finished |
USDA |
| Erwinia carotovora |
5.06 |
50.97% |
Bell et al., Proc. Natl. Acad. Sci. USA 101, 11105-11110 (2004) |
The Scottish Executive |
| Escherichia coli 042 |
5.355 |
50.5% |
Finished |
Beowulf Genomics |
| Escherichia coli E2348/69 |
4.966 |
50.6% |
Iguchi et al., J Bacteriol 191 347-354 (2009) |
Beowulf Genomics |
| Escherichia coli H10407 |
5.15 |
50.7% |
Finished |
BBSRC |
| Escherichia coli non-K1 clinical isolate |
~5.0 |
~50% |
Funded |
Beowulf Genomics |
| Haemophilus influenzae 10810 |
1.98 |
38.1% |
Finished |
Wellcome Trust |
| Haemophilus influenzae F3031 |
1.99 |
38.2% |
Finished |
Wellcome Trust |
| Haemophilus influenzae F3047 |
~2.1 |
~40% |
Finishing/ gap closure |
Wellcome Trust |
| Haemophilus parainfluenzae |
~2.1 |
39.6% |
Finished |
Wellcome Trust |
| Helicobacter mustelae |
1.58 |
42.5 |
Finished |
Wellcome Trust |
| Mycobacterium africanum |
4.39 |
65.6% |
Finished |
Wellcome Trust |
| Mycobacterium bovis AF2122/97 |
4.4 |
64% |
Garnier et al., Proc. Natl. Acad. Sci. USA 100, 7877-7882 (2003) |
DEFRA/
Beowulf Genomics |
| Mycobacterium bovis BCG |
4.4 |
65.6% |
Brosch et al., Proc. Natl. Acad. Sci. USA 104, 4496-5601 (2007) |
DEFRA/
Beowulf Genomics |
| Mycobacterium canetti |
~4.4 |
~64% |
Finishing |
Wellcome Trust |
| Mycobacterium leprae |
3.27 |
57.8% |
Cole et al., Nature 409, 1007-1011 (2001) |
Heiser/
Follereau |
| Mycobacterium marinum |
6.637 |
65.7% |
Stinear et al., Genome Research online publication (2008) |
Beowulf Genomics |
| Mycobacterium microti |
~4.4 |
~64% |
Shotgun in progress |
DEFRA/
Beowulf Genomics |
| Mycobacterium tuberculosis |
4.41 |
65.6% |
Cole et al., Nature 393, 537-544 (1998) |
Wellcome Trust |
| Mycoplasma amphoriforme |
~1.0 |
ND |
Funded |
Wellcome Trust |
| Neisseria lactamica |
2.2 |
52.3% |
Finished |
Wellcome Trust |
Neisseria meningitidis
Serogroup A strain Z2491 |
2.18 |
51.8% |
Parkhill et al., Nature 404, 502-506 (2000) |
Wellcome Trust |
Neisseria meningitidis
Serogroup C strain FAM18 |
2.19 |
51.6% |
Bentley et al., PLoS Genet. 3, e23 (2007) |
Beowulf Genomics |
| Photorhabdus asymbiotica |
5.07 |
42.2% |
Finished |
BBSRC |
| Proteus mirabilis |
4.06 |
38.88% |
Pearson et al., J. Bacteriol. 190, 4027-37 (2008) |
Wellcome Trust |
| Pseudomonas aeruginosa |
6.602 |
66.3% |
Winstanley et al., Genome Res 19, 12-23 (2009) |
Wellcome Trust |
| Pseudomonas fluorescens |
6.722 |
60.5% |
Silby et al., Genome Biology 10, r51 (2009) |
BBSRC |
| Rhizobium leguminosarum |
7.751 |
60.86% |
Young et al., Genome Biology 7, r34 (2006) |
BBSRC |
| Rhodococcus equi |
~4.5 |
~68% |
Finished |
HBLB |
| Ruminococcus flavefaciens 007c |
3.65 |
~45% |
High Quality Draft Sequence |
Wellcome Trust |
| Salmonella bongori |
4.46 |
51.3% |
Finished |
Beowulf Genomics |
| Salmonella enteritidis PT4 |
4.686 |
52.17% |
Thomson et al., Genome Research epublication, (2008) |
Beowulf Genomics |
| Salmonella gallinarum 287/91 |
4.747 |
52.2% |
Thomson et al., Genome Research epublication, (2008) |
Beowulf Genomics |
| Salmonella enterica Hadar |
4.786 |
52.3% |
Finished |
Wellcome Trust |
| Salmonella enterica Infantis |
4.711 |
~52.3% |
Finished |
Wellcome Trust |
| Salmonella paratyphi A |
4.582 |
52.2% |
Holt et al., BMC Genomics epublication, 10(1):36 (2009) |
Wellcome Trust |
| Salmonella typhimurium DT104 |
5.02 |
52.1% |
Finished |
Beowulf Genomics |
| Salmonella typhimurium D23580 |
~5.0 |
~52% |
Finishing/ gap closure |
Wellcome Trust |
| Salmonella typhimurium DT2 |
~5 |
~52% |
Shotgun in Progress |
Wellcome Trust |
| Salmonella typhimurium SL1344 |
5.067 |
52.2% |
Finished |
Beowulf Genomics |
| Salmonella typhi |
4.81 |
52.1% |
Parkhill et al., Nature 413, 848-852 (2001) |
Beowulf Genomics |
| Serratia marcescens |
5.11 |
59.5% |
Finished |
Wellcome Trust /
CNRS |
| Shigella dysenteriae |
~4.7 |
~50% |
Finishing/ gap closure |
Beowulf Genomics |
| Shigella sonnei |
4.989 |
50.7% |
Finished |
Beowulf Genomics |
| Staphylococcus aureus |
|
|
|
|
| Stenotrophomonas maltophilia |
4.851 |
66.3% |
Crossman et al. Genome Biology 9, R74 (2008) |
Wellcome Trust |
| Streptococcus equi |
2.25 |
41.3% |
Holden et al., PLoS Path. 5, e1000346 (2009) |
Home of Rest for Horses |
| Streptococcus pneumoniae |
|
|
|
|
| Streptococcus pyogenes |
1.84 |
38.6% |
Holden et al., J. Bacteriol. 188, 1473-1477 (2006) |
Beowulf Genomics |
| Streptococcus suis P1/7 |
2.01 |
41.3% |
Holden et al., PLoS One 4, e6072 (2009) |
Beowulf Genomics |
| Streptococcus suis BM407 |
2.15 |
41.1% |
Holden et al., PLoS One 4, e6072 (2009) |
Wellcome Trust |
| Streptococcus suis SC84 |
2.10 |
41.1% |
Holden et al., PLoS One 4, e6072 (2009) |
Wellcome Trust |
| Streptococcus uberis |
1.85 |
36.6% |
Ward et al., BMC Genomics 10, 54 (2009) |
Beowulf Genomics |
| Streptococcus zooepidemicus |
2.15 |
41.5% |
Holden et al., PLoS Path. 5, e1000346 (2009) |
HBLB |
| Streptomyces coelicolor |
8.67 |
72.1% |
Bentley et al., Nature 417, 141-147 (2002) |
BBSRC /
Beowulf Genomics |
| Streptomyces scabies |
10.148 |
71.45% |
Finished |
USDA |
| Tropheryma whipplei |
0.93 |
46.3% |
Bentley et al., Lancet 361, 637-644 (2003) |
Beowulf Genomics |
| Wolbachia pipientis endosymbiont of Culex quinquefasciatus |
~1.6 |
~34% |
Finishing/ gap closure |
Beowulf Genomics |
| Wolbachia endosymbiont of Onchocerca volvulus |
~1.1 |
ND |
Sequencing in progress |
Beowulf Genomics |
Yersinia enterocolitica strain 8081Biotypes |
4.62 |
42.3% |
Thomson et al. (2006) |
Wellcome TrustWellcome Trust |
| Yersinia pestis |
4.65 |
47.6% |
Parkhill et al., Nature 413, 523-527 (2001) |
Beowulf Genomics |